Related references
Note: Only part of the references are listed.Improved analysis of CRISPR fitness screens and reduced off-target effects with the BAGEL2 gene essentiality classifier
Eiru Kim et al.
GENOME MEDICINE (2021)
Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells
Xin Xu et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Synthetic lethality as an engine for cancer drug target discovery
Alan Huang et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Hilal Sarac et al.
ONCOGENE (2020)
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance
Joshi J. Alumkal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Histone Lys demethylase KDM3C demonstrates anti-inflammatory effects by suppressing NF-κB signaling and osteoclastogenesis
Jae Young Lee et al.
FASEB JOURNAL (2019)
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia
Jesus Izaguirre-Carbonell et al.
BLOOD ADVANCES (2019)
A network of human functional gene interactions from knockout fitness screens in cancer cells
Eiru Kim et al.
LIFE SCIENCE ALLIANCE (2019)
Anti-cancer therapy with TNFα and IFNγ:A comprehensive review
Jing Shen et al.
CELL PROLIFERATION (2018)
Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells
Lingling Fan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting
Francesco Iorio et al.
BMC GENOMICS (2018)
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Steven F. Josephs et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
Jiong Li et al.
NATURE COMMUNICATIONS (2017)
The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
Stephen Wilson et al.
ONCOTARGET (2017)
Evaluation and Design of Genome-Wide CRISPR/SpCas9 Knockout Screens
Traver Hart et al.
G3-GENES GENOMES GENETICS (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling
Qiji Li et al.
CANCER LETTERS (2017)
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival
L. Fan et al.
ONCOGENE (2016)
BAGEL: a computational framework for identifying essential genes from pooled library screens
Traver Hart et al.
BMC BIOINFORMATICS (2016)
Organoid culture systems for prostate epithelial and cancer tissue
Jarno Drost et al.
NATURE PROTOCOLS (2016)
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
Andrew J. Aguirre et al.
CANCER DISCOVERY (2016)
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Traver Hart et al.
CELL (2015)
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment
Mark Ammirati et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Systemic use of tumor necrosis factor alpha as an anticancer agent
Nicholas J. Roberts et al.
Oncotarget (2015)
shRNA screening identifies JMJD1C as being required for leukemia maintenance
Patrycja Sroczynska et al.
BLOOD (2014)
SOX2 regulates apoptosis through MAP4K4-Survivin signaling pathway in human lung cancer cells
Si Chen et al.
CARCINOGENESIS (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Measuring error rates in genomic perturbation screens: gold standards for human functional genomics
Traver Hart et al.
MOLECULAR SYSTEMS BIOLOGY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Genetic Screens in Human Cells Using the CRISPR-Cas9 System
Tim Wang et al.
SCIENCE (2014)
JMJD1C, a JmjC Domain-Containing Protein, Is Required for Long-Term Maintenance of Male Germ Cells in Mice
Shunsuke Kuroki et al.
BIOLOGY OF REPRODUCTION (2013)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tumor necrosis factor α (TNFα) stimulates Map4k4 expression through TNFα receptor 1 signaling to c-Jun and activating transcription factor 2
Gregory J. Tesz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR
Siegmund S. Wolf et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Tumor necrosis factor-α induces the expression of DR6, a member of the TNF receptor family, through activation of NF-κB
GM Kasof et al.
ONCOGENE (2001)
Local intratumoral tumor necrosis factor-α and systemic IFN-α2b in patients with locally advanced prostate cancer
G Kramer et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2001)
Share Paper
